Reza Madadi

Reza Madadi

Auto-generated profile, based on publicly available information

Reza Madadi

Department of Cardiology, Zanjan University of Medical sciences, Zanjan, Iran

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 June 2026 in Journal of Cardiovascular and Thoracic Research
Verified
Journal Article
Open access
PDF file
RRReza Rastgoo
Reza Rastgoo
MRMahnaz Yousefi Ramandi
Mahnaz Yousefi Ramandi
FEFereshteh Ebrahimi
Fereshteh Ebrahimi
RMReza Madadi
Reza Madadi
HKHamid Khederlou
Hamid Khederlou
ARAli Ramazani
Ali Ramazani
Introduction: Given the proven cardiovascular benefits of Empagliflozin (EM), we aimed to investigate the effect of Empagliflozin on Cardiotrophin-1 (CTF-1) and growth differentiation factor-15 (GDF-15) expressions in circulating monocytes in type 2 diabetic patients after MI. Methods: This randomized, double-blind, placebo-controlled study included 33 patients referred to Ayatollah Mousavi Hospital in Zanjan between 5 of September to 25 of December, 2024. Eligible patients with type 2 diabetes and MI who underwent primary percutaneous coronary intervention (PCI) were randomly assigned (17:16) to receive either 10 mg of EMPA daily or placebo for 12 weeks. Target genes expression levels were quantified by real time PCR, and data were analyzed by SPSS version 26. Results: Thirty-three patients were included in this study (mean age: 61.27±9.07, 66% male), mean diabetes duration was longer in intervention group (7.82±5.13) compared to placebo group (3.75±2.74), hypertension was the most common comorbidity (57%). CTF-1 expression in the intervention group was 0.3±0.28 and in placebo group was 5.66±6.52. GDF-15 expression in the intervention group was 0.198±0.22 and in placebo group was 1.66±1.04. EMPA significantly reduced expression of CTF-1 (13-fold) (P=0.003) and GDF-15 (7-fold) (P ˂ 0.0001). The CTF-1 and GDF-15 expression reduction were not associated with any other clinical variables. Significant reduction observed in LDL (P=0.045) and triglycerides (P=0.013) after intervention. Conclusion: EMPA significantly reduced the expression of CTF-1 and GDF-15 in type 2 diabetic, post MI patients, which are associated with atherosclerosis, and suggest that potential anti-atherosclerotic effect of EMPA mediated through modulation of GDF-15 and CTF-1 gene expression.

1 January 2023 in Journal of Advances in Medical and Biomedical Research
Verified
Journal Article
Open access
PDF file
SGSoleiman Gharanjik
Soleiman Gharanjik
MMMorteza Motedayen
Morteza Motedayen
RMReza Hasanzadeh Makoui
Reza Hasanzadeh Makoui
NMNima Motamed
Nima Motamed
MEMinoo Emami
Minoo Emami
RMReza Madadi
Reza Madadi
Background and Objective: Acute myocardial infarction (MI) is caused due to coronary artery occlusion and divided into two forms of ST-elevation (STEMI) and non-ST-elevation (NSTEMI) myocardial infarction. This study aimed to determine the success rate of treatment with primary PCI (percutaneous coronary intervention) versus thrombolysis in the establishment of perfusion and ...